Literature DB >> 18777497

Four decades of uncertainty: landmark trials in glycaemic control and cardiovascular outcome in type 2 diabetes.

David R Matthews1, Apostolos Tsapas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18777497     DOI： 10.3132/dvdr.2008.036

Source DB:  PubMed          Journal:  Diab Vasc Dis Res        ISSN： 1479-1641            Impact factor:   3.291


× No keyword cloud information.
  10 in total

1.  Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  S E Inzucchi; R M Bergenstal; J B Buse; M Diamant; E Ferrannini; M Nauck; A L Peters; A Tsapas; R Wender; D R Matthews
Journal:  Diabetologia       Date:  2012-04-20       Impact factor: 10.122

2.  Cardiovascular risk with DPP-4 inhibitors: latest evidence and clinical implications.

Authors:  Thomas Karagiannis; Eleni Bekiari; Panagiota Boura; Apostolos Tsapas
Journal:  Ther Adv Drug Saf       Date:  2015-12-23

Review 3.  Systematic review and meta-analysis of vildagliptin for treatment of type 2 diabetes.

Authors:  Eleni Bekiari; Chrysoula Rizava; Eleni Athanasiadou; Konstantinos Papatheodorou; Aris Liakos; Thomas Karagiannis; Maria Mainou; Maria Rika; Panagiota Boura; Apostolos Tsapas
Journal:  Endocrine       Date:  2015-12-29       Impact factor: 3.633

Review 4.  Safety of dipeptidyl peptidase 4 inhibitors: a perspective review.

Authors:  Thomas Karagiannis; Panagiota Boura; Apostolos Tsapas
Journal:  Ther Adv Drug Saf       Date:  2014-06

Review 5.  Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  Silvio E Inzucchi; Richard M Bergenstal; John B Buse; Michaela Diamant; Ele Ferrannini; Michael Nauck; Anne L Peters; Apostolos Tsapas; Richard Wender; David R Matthews
Journal:  Diabetes Care       Date:  2012-04-19       Impact factor: 19.112

Review 6.  Canagliflozin in the treatment of type 2 diabetes: an evidence-based review of its place in therapy.

Authors:  Thomas Karagiannis; Eleni Bekiari; Apostolos Tsapas
Journal:  Core Evid       Date:  2017-03-15

7.  Effect of Olea europaea leaves extract on streptozotocin induced diabetes in male albino rats.

Authors:  Atef M Al-Attar; Fawziah A Alsalmi
Journal:  Saudi J Biol Sci       Date:  2017-03-07       Impact factor: 4.219

8.  Adverse event profiles of dipeptidyl peptidase-4 inhibitors: data mining of the public version of the FDA adverse event reporting system.

Authors:  Jing Huang; Yuntao Jia; Shusen Sun; Long Meng
Journal:  BMC Pharmacol Toxicol       Date:  2020-09-16       Impact factor: 2.483

9.  Effects of Caralluma russeliana stem extract on some physiological parameters in streptozotocin-induced diabetic male rats.

Authors:  Talal A Zari; Mesfer A Al-Thebaiti
Journal:  Diabetes Metab Syndr Obes       Date:  2018-10-12       Impact factor: 3.168

Review 10.  A Review on Cardiovascular Outcome Studies of Dipeptidyl Peptidase-4 Inhibitors.

Authors:  Maneesha Khalse; Amit Bhargava
Journal:  Indian J Endocrinol Metab       Date:  2018 Sep-Oct
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.